News tagged with biomed central

Related topics: breast cancer · protein

Reducing the side effects of treatment for prostate cancer

New research published in BioMed Central's open access journal BMC Medicine reassessing clinical data from trials, which investigate ways of treating side effects of therapy for prostate cancer, finds that tamoxifen, an anti-estrogen ...

Aug 27, 2012
popularity0 comments 0

How a virus might make you diabetic later in life

Cytomegalovirus (CMV) is one of the viruses that most infected people carry without ill effects. Once infected you are infected for life and, although it normally is dormant, it can become active again at any point in time. ...

Aug 27, 2012
popularity0 comments 0

What's best for very low birth weight babies

While the health benefits of breast feeding baby are well known, a new study published in BioMed Central's open access journal BMC Pediatrics finds that, for very low birth weight (VLBW) babies, a small amount of fortification ...

Aug 16, 2012
popularity0 comments 0

Dying of cold: Hypothermia in trauma victims

Hypothermia in trauma victims is a serious complication and is associated with an increased risk of dying. A new study published in BioMed Central's open access journal Critical Care has found that the key risk factor was ...

Jul 30, 2012
popularity0 comments 0

BioMed Central

BioMed Central (BMC) is a UK-based for-profit scientific publisher specializing in open access publication. BMC publishes over 180 scientific journals, and describes itself as the first and largest open access science publisher. BMC sister companies publish the Chemistry Central and PhysMath Central journals. The Chairman is Vitek Tracz and the Publisher is Matt Cockerill.

Most titles are open access, including its flagship journals Journal of Biology, Molecular Cancer Malaria Journal, the innovative Journal of Negative Results in BioMedicine and the BMC journal series including the leading titles BMC Biology and BMC Medicine. Others are open access for the research articles portion only, such as Genome Biology, Arthritis Research & Therapy, Breast Cancer Research, andCritical Care. Some review titles, such as Current Opinion in Drug Discovery & Development are entirely subscription based. Open access content is released under the Creative Commons "Attribution" license which grants permission to reuse publications and produce derivative work.

In October 2008, it was announced that BMC, Chemistry Central, and PhysMath Central, had been acquired by Springer Science+Business Media. Previously, since its creation, the company was part of Science Navigation Group, chaired by Vitek Tracz, which also owns The Scientist (a popular science magazine—the daily news section is free access; the remainder is by subscription), Faculty of 1000 (a subscription-only current awareness service highlighting recent biological research), Global DataPoint, People's Archive and, in the past, two other companies which had previously been acquired by Springer, Images.MD (a medical image database) and Current Medicine.

In November 2008, BMC became an official supporting organisation of HIFA2015 (Healthcare Information For All by 2015).

This text uses material from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed